Senate Bill 1681
116th Congress(2019-2020)
Advancing Education on Biosimilars Act of 2020
Active
Amendments
Passed Senate on Dec 17, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1681
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
checkPassed on December 17, 2020
Status
Passed
Type
Unanimous Consent
Unanimous Consent
A senator may request unanimous consent on the floor to set aside a specified rule of procedure so as to expedite proceedings. If no Senator objects, the Senate permits the action, but if any one senator objects, the request is rejected. Unanimous consent requests with only immediate effects are routinely granted, but ones affecting the floor schedule, the conditions of considering a bill or other business, or the rights of other senators, are normally not offered, or a floor leader will object to it, until all senators concerned have had an opportunity to inform the leaders that they find it acceptable.
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
Summary
Advancing Education on Biosimilars Act of 2019
This bill addresses education for the public and for health care providers regarding biosimilars. (Biosimilars are biological products approved by the Food and Drug Administration based on their similarity to an already approved biological product.)
The bill requires the Department of Health and Human Services (HHS) to create a website for educational materials on the meaning and use of biosimilars and interchangeable biological products.
HHS must also develop or improve continuing medical education programs for health care providers regarding biosimilars.
Amendments (1)
Dec 17, 2020
Agreed to in Senate
1
Sponsorship
Senate Amendment 2716
In the nature of a substitute.
Agreed To
Sort by most recent
12/18/2020
Held at the desk.
12/18/2020
Received in the House.
12/18/2020
Message on Senate action sent to the House.
12/17/2020
Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7643)
12/17/2020
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
12/17/2020
Measure laid before Senate by unanimous consent. (consideration: CR S7642-7643)
12/17/2020
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
05/23/2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
05/23/2019
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:43:53 PM